Skip to main content

ADVERTISEMENT

Erin McGuinness

News
11/29/2021
Experts have used rapid prototyping and human factors studies (HFS) to develop Floodlight MS, an application that can be used for remote functional assessment of multiple sclerosis (MS). These details were presented in a poster presented at...
Experts have used rapid prototyping and human factors studies (HFS) to develop Floodlight MS, an application that can be used for remote functional assessment of multiple sclerosis (MS). These details were presented in a poster presented at...
Experts have used rapid...
11/29/2021
Neurology
Conference Coverage
02/09/2022
Management of unruptured arteriovenous malformations (AVMs) has changed since the publishing of the ARUBA trial findings, according to data presented at ISC 2022.
Management of unruptured arteriovenous malformations (AVMs) has changed since the publishing of the ARUBA trial findings, according to data presented at ISC 2022.
Management of unruptured...
02/09/2022
Neurology
News
09/07/2021
A recent meta-analysis mapping rates of young-onset dementia found that 119 per 100 000 patients between the ages of 30 and 64 are affected.
A recent meta-analysis mapping rates of young-onset dementia found that 119 per 100 000 patients between the ages of 30 and 64 are affected.
A recent meta-analysis mapping...
09/07/2021
Psych Congress Network
News
09/27/2021
Patients with multiple sclerosis (MS) treated with ocrelizumab can develop vaccine-specific T-cell responses to the SARS-CoV-2 messenger RNA vaccine, despite ocrelizumab being a B-cell-depleting agent, according to new research published in...
Patients with multiple sclerosis (MS) treated with ocrelizumab can develop vaccine-specific T-cell responses to the SARS-CoV-2 messenger RNA vaccine, despite ocrelizumab being a B-cell-depleting agent, according to new research published in...
Patients with multiple sclerosis...
09/27/2021
Neurology
News
10/05/2021
Dietary interventions to adjust fatty acid intake combined with usual care can help improve variability of mood related symptoms for patients with bipolar disorders (BD), according to new research from the Penn State College of Medicine...
Dietary interventions to adjust fatty acid intake combined with usual care can help improve variability of mood related symptoms for patients with bipolar disorders (BD), according to new research from the Penn State College of Medicine...
Dietary interventions to adjust...
10/05/2021
Psych Congress Network
News
12/16/2021
A comparative effectiveness study incorporating electronic health records (EHR) data found rituximab had better relapse outcomes versus natalizumab, and similar outcomes between dimethyl fumarate and fingolimod, according to new findings...
A comparative effectiveness study incorporating electronic health records (EHR) data found rituximab had better relapse outcomes versus natalizumab, and similar outcomes between dimethyl fumarate and fingolimod, according to new findings...
A comparative effectiveness...
12/16/2021
Neurology
News
11/22/2021
Sleep quality for patients with multiple sclerosis (MS) could be improved using the over the counter medication melatonin, according to new research published in Multiple Sclerosis Journal.
Sleep quality for patients with multiple sclerosis (MS) could be improved using the over the counter medication melatonin, according to new research published in Multiple Sclerosis Journal.
Sleep quality for patients with...
11/22/2021
Neurology
News
09/18/2021
Rosalind Watts, PhD, Clinical Director, Synthesis Institute, London, England, discussed the therapeutic relationship in psilocybin treatment for depression during a virtual presentation at Sana Symposium.
Rosalind Watts, PhD, Clinical Director, Synthesis Institute, London, England, discussed the therapeutic relationship in psilocybin treatment for depression during a virtual presentation at Sana Symposium.
Rosalind Watts, PhD, Clinical...
09/18/2021
Psych Congress Network
News
08/26/2021
Coronavirus fears, fears related to COVID-19, are a new psychological effect that impacts severity of anxiety and depressive disorder symptoms, according to analyses published in Frontiers in Psychology.
Coronavirus fears, fears related to COVID-19, are a new psychological effect that impacts severity of anxiety and depressive disorder symptoms, according to analyses published in Frontiers in Psychology.
Coronavirus fears, fears related...
08/26/2021
Psych Congress Network
News
09/21/2021
Alzheimer disease (AD) co-pathology is associated with presence and severity of neuropsychiatric symptoms in Lewy body dementia, according to recent findings presented at MDS Virtual Congress 2021.
Alzheimer disease (AD) co-pathology is associated with presence and severity of neuropsychiatric symptoms in Lewy body dementia, according to recent findings presented at MDS Virtual Congress 2021.
Alzheimer disease (AD)...
09/21/2021
Neurology